Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ISL1 divergent transcript (ISL1-DT) is a gene that codes for a long non-coding RNA. It is located in close genomic proximity to the ISL1 gene and is transcribed from the opposite strand. ISL1-DT is classified as a divergent lncRNA, meaning it is not translated into a protein. Its expression pattern closely mirrors that of ISL1 in certain tissues, but ISL1-DT is consistently found at lower abundance. Current evidence suggests that ISL1-DT may be involved in the regulatory landscape around the ISL1 locus, with potential co-regulation mechanisms mediated through shared or adjacent promoter regions and chromatin interactions; however, its precise biological function and role in disease are not well characterized, and it is not established as a therapeutic target[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ISL1 divergent transcript (ISL1-DT).